Archives

by in
Entry Author Date Location
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the First Quarter 03/31/11 Boston
Vertex CF Drug Shines in Late-Stage Study in Children 03/29/11 Boston
Think Obamacare Will Suffocate New Drug Development With Price Controls? Think Again 03/21/11 National
Where Are Tomorrow’s Blockbuster Biotech Drugs Coming From? You Might be Surprised 03/14/11 National
Targeted Genetics, Re-invented as AmpliPhi, Bets on Anti-Bacterials, Moves HQ to London 03/09/11 Seattle
Quanterix Partners With Novartis, Athenahealth and Microsoft Sync Up, Vertex Nails Clinical Trial, & More Boston-Area Life Sciences News 02/25/11 Boston
Vertex Stock Up 15 Percent on CF Data 02/23/11 Boston
Vertex Nails Pivotal Study for Cystic Fibrosis, Racing Toward Market With Second Drug 02/23/11 Boston
Philanthropist John Flatley Starts Venture Group to Back New Cystic Fibrosis Treatments 01/27/11 Boston
Vertex Drug Gets Speedy FDA Review, BSX Buys Atritech, Ironwood Strikes Another Deal, & More Boston-Area Life Sciences News 01/21/11 Boston
Patients’ Parents Upset By FDA Panel’s Rejection of Lilly/Alnara’s Cystic Fibrosis Drug 01/19/11 Boston
ModeRNA, Stealth Startup Backed By Flagship, Unveils New Way to Make Stem Cells 10/04/10 Boston
Genzyme Boss Henri Termeer Not Ready To Sell to Sanofi, Ride Into the Sunset, Sources Say 09/22/10 Boston
Good Start Genetics Emerges from Stealth with $18M Series A Round 09/10/10 Boston
PacBio Seeks $200M IPO, Complete Genomics Adds $39M, Siluria Envisions Cleaner Plastics, & More Bay Area Life Sciences News 08/20/10 San Francisco
KaloBios, Seeking to Apply Antibodies Beyond Cancer, Sets Sight on Killing Deadly Lung Invader 08/17/10 San Francisco
Gilead’s Lung Drug Ace, Bruce Montgomery, Hits Free Agent Market, Scopes Startup Ideas 08/05/10 Seattle
Lucky 13: Xconomy Boston’s Top Stories of 2010 (So Far) 07/23/10 Boston
AlloCure Arrives in New England, Merck Shutters Cambridge Research Site, Infinity Cuts Deal With Intellikine, & More Boston-Area Life Sciences News 07/09/10 Boston
Alnara Pharma Used “Flexible” Strategy on Road to Eli Lilly Deal 07/08/10 Boston
Drug Giant Eli Lilly Buys Alnara Pharma To Get Cystic Fibrosis Drug 07/02/10 Boston
Seattle Genetics’ Dark Horse, Gilead Beats Novartis, Oncothyreon Back in the Saddle, & More Seattle-Area Life Sciences News 06/24/10 Seattle
Gilead CF Drug Passes Trial 06/18/10 San Francisco
FoldRx Pharma Finds $29M, Plans to Seek Approval of First Drug in 2010 06/15/10 Boston
Sequenom Highlights Its Good News, Keeps Lid on Bad 03/15/10 San Diego
Bruce Montgomery Joins Zymo Board 03/11/10 Seattle
Avila Sets Out to Take on Vertex, CombinatoRx Nails FDA Approval, Millipore Opts for Merck KGaA over Thermo Fisher, & More Boston-Area Life Sciences News 03/05/10 Boston
Prominent Flatley Family Launches Boston Nonprofit for Cystic Fibrosis Drug Research 03/03/10 Boston
Gilead Sciences Gets FDA Green Light To Sell Cystic Fibrosis Drug 02/23/10 Seattle
Alnara Bags $35M B Round, Plans to Seek FDA Approval for Cystic Fibrosis Drug 01/28/10 Boston
Page 2 of 4 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.